✦ LIBER ✦

Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

✍ Scribed by Dr. James O. Armitage; Fred R. Dick; Michael P. Corder; Stewart C. Garneau; Charles E. Platz; Donald J. Slymen

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 628 KB
Volume: 50
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19821101)50:9<1695::aid-cncr2820500907>3.0.co;2-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination chemotherapy of diffuse hist

Combination chemotherapy of diffuse histiocytic lymphoma with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP)

✍ Laurence Elias; Carol S. Portlock; Saul A. Rosenberg 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 497 KB 👁 2 views

Twenty-three patients with diffuse histiocytic lymphoma who had not had prior chemotherapy were treated with CHOP (cyclophosphamide, adriamycin, vincristine, and prednisone). Sixteen of these patients had previously been treated with radiation therapy. Nine of these 23 patients had a pathologically

Cyclophosphamide, vincristine, adriamyci

Cyclophosphamide, vincristine, adriamycin, and prednisone (CHOP) with and without intermediate dose methotrexate for the treatment of non-Hodgkin's lymphomas of diffuse histology

✍ German A. Gomez; Maurice Barcos; Tin Han; Edward S. Henderson 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 702 KB

Liposome-encapsulated doxorubicin in com

Liposome-encapsulated doxorubicin in combination with cyclophosphamide, vincristine, prednisone and rituximab in patients with lymphoma and concurrent cardiac diseases or pre-treated with anthracyclines

✍ Luigi Rigacci; Silvia Mappa; Luca Nassi; Renato Alterini; Valentina Carrai; Fran 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

## Abstract ## Background To assess the efficacy and safety of the combination of non‐pegylated liposome‐encapsulated doxorubicin (Myocet®) with cyclophosphamide, vincristine, prednisone and rituximab (R‐COMP) in patients with aggressive non‐Hodgkin's B‐cell lymphomas. ## Methods Twenty‐one pati

A pilot study of epratuzumab and rituxim

A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma

✍ Ivana N. M. Micallef; Brad S. Kahl; Matthew J. Maurer; Ahmet Dogan; Stephen M. A 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

Cost utility in the United States of rit

Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma

✍ John C. Hornberger; Jennie H. Best 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

Activity and safety of dose-adjusted inf

Activity and safety of dose-adjusted infusional cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy with rituximab in very elderly patients with poor-prognostic untreated diffuse large B-cell non-Hodgkin lymphoma

✍ Antonino Musolino; Daniela Boggiani; Michele Panebianco; Giovanna Vasini; Stefan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 222 KB 👁 1 views